Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
28.16%
Operating Margin
11.03%
Net Margin
1.24%
Efficiency Metrics
Revenue per Expense Ratio
1.12
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
24.69%
Income Tax Rate
14.78%
EPS
-0.0488000000
Balance Sheet Analysis
Current Ratio
2.83
Cash Ratio
0.26
Working Capital
$212.82M
Debt to Equity
2.66
Debt to Assets
59.32%
Equity Ratio
22.34%
Cash Flow Analysis
Operating Cash Flow Ratio
13.82%
Free Cash Flow Ratio
10.13%
CapEx to Revenue
3.69%
Dividends Paid
$80.40M
Stock Buybacks
$12.84M
Total Shareholder Returns
$93.23M
Cash Position Change
-41.84%
Key Takeaways (2023 FY)
Increased dividend payments by 46.52%
Detailed Growth Metrics
Core Performance
Revenue
46.90%
Net Income
-88.91%
EPS
-106.78%
Operating Income
-9.32%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
15.49%
Operating Cash Flow
-20.15%
Free Cash Flow
-6.47%
Balance Sheet Health
Assets
14.30%
Debt
25.28%
Book Value per Share
17.80%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
46.52%
Shares Outstanding
-24.39%
Long Term Trends
3Y Revenue/Share
49.26%
5Y Revenue/Share
145.49%
3Y Dividend/Share
44.96%
5Y Dividend/Share
12.36%